Literature DB >> 24611991

Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity.

Lucinda J Black1, Peter Jacoby, Wendy Chan She Ping-Delfos, Trevor A Mori, Lawrence J Beilin, John K Olynyk, Oyekoya T Ayonrinde, Rae Chi Huang, Patrick G Holt, Prue H Hart, Wendy H Oddy, Leon A Adams.   

Abstract

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) and serum 25-hydroxyvitamin D (s25[OH]D) concentrations are both associated with adiposity and insulin resistance (IR) and thus may be pathogenically linked. We aimed to determine the prevalence of vitamin D deficiency in adolescents with NAFLD and to investigate the prospective and cross-sectional associations between s25[OH]D concentrations and NAFLD.
METHODS: Participants in the population-based West Australian Pregnancy (Raine) Cohort had seasonally adjusted s25(OH)D concentrations determined at ages 14 and then 17 years. NAFLD was diagnosed at 17 years using liver ultrasonography. Associations were examined after adjusting for potential confounders. Odds ratios (ORs) and confidence intervals (CIs) are reported per standard deviation in s25(OH)D concentrations.
RESULTS: NAFLD was present in 16% (156/994) of adolescents. The majority of participants with NAFLD had either insufficient (51%) or deficient (17%) vitamin D status. s25(OH)D concentrations at 17 years were inversely associated with risk of NAFLD (OR 0.74, 95% CI 0.56, 0.97; P = 0.029), after adjusting for sex, race, physical activity, television/computer viewing, body mass index, and IR. The effect of s25(OH)D concentrations at 17 years was minimally affected after further adjusting for s25(OH)D concentrations at 14 years (OR 0.76, 95% CI 0.56, 1.03; P = 0.072).
CONCLUSIONS: Lower s25(OH)D concentrations are significantly associated with NAFLD, independent of adiposity and IR. Screening for vitamin D deficiency in adolescents at risk of NAFLD is appropriate, and clinical trials investigating the effect of vitamin D supplementation in the prevention and treatment of NAFLD may be warranted.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  25-hydroxyvitamin D; non-alcoholic fatty liver disease; obesity

Mesh:

Substances:

Year:  2014        PMID: 24611991     DOI: 10.1111/jgh.12541

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  28 in total

1.  Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.

Authors:  Xiang Wang; Weiping Li; Ying Zhang; Yang Yang; Guijun Qin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

4.  Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease.

Authors:  Toshifumi Yodoshi; Sarah Orkin; Ana Catalina Arce-Clachar; Kristin Bramlage; Chunyan Liu; Lin Fei; Faris El-Khider; Srinivasan Dasarathy; Stavra A Xanthakos; Marialena Mouzaki
Journal:  Eur J Clin Nutr       Date:  2019-08-23       Impact factor: 4.016

5.  Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms.

Authors:  Sara Shojaei Zarghani; Hamid Soraya; Mohammad Alizadeh
Journal:  Eur J Nutr       Date:  2016-12-17       Impact factor: 5.614

6.  Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment.

Authors:  Ginger E Nicol; Lisa de Las Fuentes; Amy E Riek; Carlos Bernal-Mizrachi; Eric J Lenze; J Phillip Miller; Julia A Schweiger; Michael D Yingling; Vincent J Huang; David J Dixon; Charles H Hennekens; John W Newcomer
Journal:  J Clin Endocrinol Metab       Date:  2015-07-17       Impact factor: 5.958

Review 7.  Nonmedicinal interventions in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Radu M Nanau; Lawrence B Cohen
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

Review 8.  Obesity and hypovitaminosis D: causality or casualty?

Authors:  Silvia Migliaccio; Andrea Di Nisio; Chiara Mele; Lorenzo Scappaticcio; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

Review 9.  Vitamin D insufficiency and insulin resistance in obese adolescents.

Authors:  Catherine A Peterson; Aneesh K Tosh; Anthony M Belenchia
Journal:  Ther Adv Endocrinol Metab       Date:  2014-12       Impact factor: 3.565

10.  High fat diet enriched with saturated, but not monounsaturated fatty acids adversely affects femur, and both diets increase calcium absorption in older female mice.

Authors:  Yang Wang; Peter Dellatore; Veronique Douard; Ling Qin; Malcolm Watford; Ronaldo P Ferraris; Tiao Lin; Sue A Shapses
Journal:  Nutr Res       Date:  2016-03-03       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.